RDY launched four products in the U.S., including Icosapent Ethyl Capsules, Ertapenem Injection, Sapropterin 100 milligram sachet, and Albendazole Tablets and relaunched Famotidine Tablets....
The company is experiencing lawsuits, including one for the marketing of opioid drugs. Recently, the United States government revealed a lawsuit against the drugmaker,...
The Company is collaborating with Novartis on a LUMAKRAS combination study with their SHP 2 inhibitor TNO155. A cohort is expected to initiate in...
In July 2021, Pfizer issued a voluntary recall in the U.S. for twelve lots of Chantix due to the presence of a nitrosamine, N...
BHC plans to pursue an IPO of its Solta Medical business. Solta is a leading global provider in medical aesthetics with innovative and effective...
Gilead’s approved HIV medicines have contributed 77% of total revenue in Q2FY21. Gilead’s drug Biktarvy is now the largest product in HIV treatment and...
NVS expect to launch Leqvio in Q3FY21. In U.K., it is partnering with the NHS to bring Leqvio to more than 300,000 patients at...
JNJ received EU approval for PONVORY in relapsing multiple sclerosis and also a U.S. approval of RYBREVANT for the treatment of patients with locally...
BIIB plans to strengthen its MS portfolio with the collaboration with InnoCare . The company is paying $125mn upfront to work on InnoCare’s orelabrutinib...
AZN acquired Alexion in Jul 21 which will allow the company to expand into new and broader indications in immunology, and to bring Alexion...
Boutique research firm providing Business, Investment and M&A research services focused on fast growing Technology, Healthcare, Life science and Industrial sectors.
George Thangaiah Complex,
13, 80 Feet Rd, Near Sir CV Raman Hospital,
Indiranagar, Bengaluru, Karnataka – 560038
Ph: +91-9916444778